Showing results (2221-2230 of 2,300) with videos related to
Sort By:
Pageof 230
ESC Heart Failure|June 23, 2018
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)Anne-Catherine Pouleur, Stefan Anker, Dulce Brito, et al.European Journal of Heart Failure|July 14, 2011
Novel correlations between the genotype and the phenotype of hypertrophic and dilated cardiomyopathy: results from the German Competence Network Heart FailureStephan Waldmüller, Jeanette Erdmann, Priska Binner, et al.American Heart Journal|July 8, 2023
Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism-the Find-AF 2 study-rationale and designTobias Uhe, Katrin Wasser, Mark Weber-Krüger, et al.Journal of Thrombosis and Thrombolysis|September 1, 2016
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort studyStavros V Konstantinides, Stefano Barco, Stephan Rosenkranz, et al.Nature|April 8, 2003
Catastrophic ape decline in western equatorial AfricaPeter D Walsh, Kate A Abernethy, Magdalena Bermejo, et al.Cancer Cell|April 12, 2017
Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaSebastian Mohr, Carmen Doebele, Federico Comoglio, et al.JAMA Cardiology|September 20, 2023
Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease: The Beta3-LVH Phase 2b Randomized Clinical TrialJean-Luc Balligand, Dulce Brito, Oana Brosteanu, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 2, 2026
Effects of Elexacaftor/Tezacaftor/Ivacaftor on cough frequency, physical activity patterns, and sleep quality in adolescents and adults with cystic fibrosisEva Van Braeckel, Andrew T Braun, Nicholas J Simmonds, et al.European Journal of Heart Failure|May 13, 2016
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimensMichele Senni, John J V McMurray, Rolf Wachter, et al.Neurology|March 10, 2022
Prolonged Cardiac Monitoring and Stroke Recurrence: A Meta-analysisGeorgios Tsivgoulis, Sokratis Triantafyllou, Lina Palaiodimou, et al.Pageof 230